Human PODXL Ready-To-Use IHC Kit PRKCB2 Conjugation None Clone# Efalizumab Formulation

Conjugation None Clone# Efalizumab Formulation 100 mM Pro-Ac 20mM Arg pH 5

Cyclin dependent kinase 4

: IHC0666M

CCR7 is particularly expressed in lymphoid tissues and in activated B and T lymphocytes and has been shown to control the migration of memory T cells to inflamed tissues

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Rat CD16 Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (Goat Anti-Rabbit IgG H&L

Human PODXL Ready-To-Use IHC Kit PRKCB2 Conjugation None Clone# Efalizumab FormulationHuman PODXL Ready To Use IHC Kit Cat. No.: IHC0639H Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background This gene encodes a member of the sialomucin protein family. The encoded protein was originally identified as an important component of glomerular podocytes.